All lobbying filings

Capitol Counsel LLC

Capitol Counsel LLC filed a Q1 report for Emergent Biosolutions on April 15, 2026, reporting $50,000 in lobbying income.

Lobbying for Emergent Biosolutions · Bio pharmaceutical company.

As filed: CAPITOL COUNSEL LLC for EMERGENT BIOSOLUTIONS.

All filings by Capitol Counsel LLC · Everything Emergent Biosolutions has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 15, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

KAREN STONE New on this filing

Previously held: Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY); Senior Legislative Assistant, Rep. Steve Israel (D-NY).

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Providing guidance on development, acquisition and stockpiling of medical countermeasures for the US government. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA). Funding for medical countermeasure enterprise including, SNS, BARDA and Project BioShield; State Opioid Response (SOR) Grant Funding; Substance Abuse and Mental Health Block Grant (SABG) funding. Naloxone access and awareness and opioid prescribing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.